Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Not Yet Recruiting2
Completed1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 1 completed trials

Clinical Trials (4)

Showing 4 of 4 trials
NCT07610642Not ApplicableNot Yet RecruitingPrimary

Amnioinfusion for Chorioamnionitis: Targeting Neonatal Brain Injury Biomarkers

NCT07211503Not Yet Recruiting

IL-6 and Lactates in Cord Blood and Neonatal Outcomes

NCT07152106Recruiting

Amniotic Fluid & the Preterm Gut

NCT02996279CompletedPrimary

Chorioamnionitis and Proinflammatory S100A12

Showing all 4 trials

Research Network

Activity Timeline